HikariQ Health

Innovating immunoassay and antibody therapeutics with Q-body technology

Minato, Japan · Founded 2021 · $490K raised

Headquarters
Minato
Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$490K
Last Round
$490K SeedJan 2023
Rounds
1

About

HikariQ Health is a Tokyo-based biotech startup founded in 2021, spun out of the Tokyo Institute of Technology. The company develops innovative immunoassay methods and antibody drugs based on its proprietary Q-body technology — a fluorescent biosensor that enables wash-free, single-step antigen detection by encapsulating chemicals through antibody structural modification. HikariQ is also applying its Q-body platform to the development of antibody-drug conjugates and antibody pharmaceuticals.

Summary

HikariQ Health is a Biotech company based in Minato, Japan, founded in 2021. It has raised $490K in total across 1 round, most recently a $490K Seed round in Jan 2023. Investors include Coral Capital and 500 Startups Japan.

Tech & App Stack

2 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJan 2023
$490K

Investors

Similar Companies